Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… TRANDOLAPRIL Tablet; 1MG MAVIK Abbott 020528 TRANDOLAPRIL Tablet; 2MG MAVIK Abbott 020528 TRANDOLAPRIL Tablet; 4MG MAVIK Abbott 020591 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE Tablet, Extended Release; 1MG;240MG TARKA Abbott 020591 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE Tablet, Extended Release; 2MG;180MG TARKA Abbott 020591 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE Tablet, Extended Release; 2MG;240MG TARKA Abbott 020591 TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE Tablet, Extended Release; 4MG;240MG TARKA Abbott Mavik (trandolapril) Tablets, Abbott Laboratories | Trandolapril Tablets, Lupin Ltd., Tentative Approval | Trandolapril Tablet, Teva Pharma, Approval | Trandolapril Tablets, Cobalt Pharma, Approval | Trandolapril Tablets, Aurobindo Pharma, Approval | Trandolapril Tablets, InvaGen Pharma, Approval | Trandolapril Tablets, Lupin Ltd., Approval | Trandolapril Tablets, CorePharma, Approval | Trandolapril Tablets, Cipla Ltd., Approval | Tarka (trandolapril/verapamil hydrochloride) Extended Release Tablets, Abbott Labs, Labeling Revision | Trandolapril Tablets, Mylan Pharma, Approval | Trandolapril Tablets, Glenmark Generics Inc., USA, Approval | Trandolapril Tablets, Dr. Reddy's Laboratories, Ltd., Approval | Tarka (trandolopril and verapamil hydrochloride) Extended-Release Tablets, Abbott Laboratories, Inc., Labeling Revision | Mavik (trandolapril) Tablets, Abbott Laboratories (GPRA), Labeling Revision | Trandolapril and Verapamil Hydrochloride Extended-Release Tablets, Glenmark Generics, Tentative Approval | Mavik (trandolapril) Tablets, Abbott Laboratories, Labeling Revision | Trandolapril and Verapamil Hydrochloride Extended-Release Tablets, Glenmark Generics Inc., Approval | Trandolapril and Verapamil Hydrochloride Extended-Release Tablets, Glenmark Generics, Ltd., Approval | Tarka (trandolapril and verapamil hydrochloride) Extended-Release Tablets, Abbot Laoratories, Labeling Revision | Mavik (trandolapril) Tablets, Abbott Laboratories, Labeling Revision | Tarka (trandolapril and verapamil hydrochloride) Extended-Release Tablets, Abbott Laboratories, Labeling Revision | Tarka (trandolapril and verapamil hydrochloride) Tablets, Abbott Laboratories, Labeling Revision | Mavik, trandolapril, Tablet; Oral, Abbott, Labeling Revision | Tarka, trandolapril; verapamil hydrochloride, Tablet, Extended Release; Oral, Abbott, Labeling Revision | Mavik, trandolapril, Tablet; Oral, Abbott, Labeling Revision | Tarka, trandolapril; verapamil hydrochloride, Tablet, Extended Release; Oral, Abbott, Labeling Revision | Mavik, trandolapril, Tablet; Oral, Abbvie, Manufacturing Change or Addition ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2013 Betterchem.com